Share price & Turnover
Calendar
| 2024-11-07 | Quarterly Report 2024-Q3 |
| 2024-08-15 | Quarterly Report 2024-Q2 |
| 2024-05-16 | Quarterly Report 2024-Q1 |
| 2024-03-21 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2024-03-20 | Annual General meeting |
| 2024-02-27 | Year-end Report 2023 |
| 2023-11-09 | Quarterly Report 2023-Q3 |
| 2023-08-17 | Quarterly Report 2023-Q2 |
| 2023-05-11 | Quarterly Report 2023-Q1 |
| 2023-03-30 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2023-03-29 | Annual General meeting |
| 2023-03-02 | Year-end Report 2022 |
| 2022-11-10 | Quarterly Report 2022-Q3 |
| 2022-08-11 | Quarterly Report 2022-Q2 |
| 2022-05-12 | Quarterly Report 2022-Q1 |
| 2022-05-09 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2022-04-06 | Annual General meeting |
| 2022-03-10 | Year-end Report 2021 |
| 2021-11-11 | Quarterly Report 2021-Q3 |
| 2021-08-12 | Quarterly Report 2021-Q2 |
| 2021-05-12 | Quarterly Report 2021-Q1 |
| 2021-04-16 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2021-04-15 | Annual General meeting |
| 2021-03-11 | Year-end Report 2020 |
| 2020-11-12 | Quarterly Report 2020-Q3 |
| 2020-08-13 | Quarterly Report 2020-Q2 |
| 2020-05-14 | Quarterly Report 2020-Q1 |
| 2020-04-03 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2020-04-02 | Annual General meeting |
| 2020-03-12 | Year-end Report 2019 |
| 2019-11-14 | Quarterly Report 2019-Q3 |
| 2019-08-15 | Quarterly Report 2019-Q2 |
| 2019-05-16 | Quarterly Report 2019-Q1 |
| 2019-04-05 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2019-04-04 | Annual General meeting |
| 2019-03-07 | Year-end Report 2018 |
| 2018-11-15 | Quarterly Report 2018-Q3 |
| 2018-08-16 | Quarterly Report 2018-Q2 |
| 2018-05-16 | Quarterly Report 2018-Q1 |
| 2018-04-20 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2018-04-19 | Annual General meeting |
| 2018-03-07 | Year-end Report 2017 |
| 2017-11-08 | Quarterly Report 2017-Q3 |
| 2017-08-24 | Quarterly Report 2017-Q2 |
| 2017-05-17 | Quarterly Report 2017-Q1 |
| 2017-04-06 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2017-04-05 | Annual General meeting |
| 2017-03-15 | Year-end Report 2016 |
| 2016-11-09 | Quarterly Report 2016-Q3 |
| 2016-08-25 | Quarterly Report 2016-Q2 |
| 2016-05-18 | Quarterly Report 2016-Q1 |
| 2016-04-20 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2016-04-19 | Annual General meeting |
| 2016-03-16 | Year-end Report 2015 |
| 2015-11-05 | Quarterly Report 2015-Q3 |
| 2015-08-28 | Quarterly Report 2015-Q2 |
| 2015-05-22 | Quarterly Report 2015-Q1 |
| 2015-04-22 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2015-04-21 | Annual General meeting |
| 2015-03-12 | Year-end Report 2014 |
| 2014-11-07 | Quarterly Report 2014-Q3 |
| 2014-08-21 | Quarterly Report 2014-Q2 |
| 2014-05-06 | Capital Market Day 2014 |
| 2014-04-29 | Quarterly Report 2014-Q1 |
| 2014-04-29 | Annual General meeting |
| 2014-03-21 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2014-03-20 | Year-end Report 2013 |
| 2013-11-15 | Quarterly Report 2013-Q3 |
| 2013-08-29 | Quarterly Report 2013-Q2 |
| 2013-05-15 | Quarterly Report 2013-Q1 |
| 2013-04-30 | Annual General meeting |
| 2013-04-30 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2013-03-14 | Year-end Report 2012 |
| 2012-11-29 | Capital Market Day 2012 |
| 2012-04-26 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2012-04-25 | Annual General meeting |
| 2011-11-17 | Quarterly Report 2011-Q3 |
| 2011-10-25 | Capital Market Day 2011 |
| 2011-08-18 | Quarterly Report 2011-Q2 |
| 2011-05-12 | Quarterly Report 2011-Q1 |
| 2011-04-29 | Ex-date Ordinary Dividend ZEAL 0.00 DKK |
| 2011-04-28 | Annual General meeting |
Description
| Country | Denmark |
|---|---|
| List | Large Cap Copenhagen |
| Sector | Health care |
| Industry | Biotechnology |
Press release – No. 5 / 2024
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
Copenhagen, Denmark, May 29, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that Adam Steensberg, President and CEO, will participate in fireside chats at the following healthcare investor conferences in June:
- Jefferies Global Healthcare Conference, June 4-6 in New York City
Wednesday, June 5 at 10:00 a.m. ET (4:00 p.m. CET)
A webcast of the fireside chat will be available at https://wsw.com/webcast/jeff302/register.aspx?conf=jeff302&page=zeal&url=https://wsw.com/webcast/jeff302/zeal/1839808 and accessible through the Events page in the Investor section of Zealand Pharma’s website at https://www.zealandpharma.com/events/ where a replay will also be archived after the fireside chat.
- Goldman Sachs 45th Annual Global Healthcare Conference, June 10-13 in Miami
Wednesday, June 12 at 4:00 p.m. ET (10:00 p.m. CET)
A webcast of the fireside chat will be available at https://event.webcasts.com/starthere.jsp?ei=1672947&tp_key=a29a9e2b8f&tp_special=8 and accessible through the Events page in the Investor section of Zealand Pharma’s website at https://www.zealandpharma.com/events/ where a replay will also be archived after the fireside chat.
# # #
About Zealand Pharma
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand’s business and activities, please visit www.zealandpharma.com.
Contacts:
| Adam Lange (Investors) |
| Investor Relations Officer |
| Zealand Pharma |
| akl@zealandpharma.com |
| Anna Krassowska, PhD (Investors and Media) |
| Vice President, Investor Relations & Corporate Communications |
| Zealand Pharma |
| ank@zealandpharma.com |